Biggest Risks (and Possible Rewards) of AI in Clinical Data
Are we any closer to working out the human-machine relationship needed to embed AI in clinical development? To discuss this and all things automation, Veeva’s Chief Technology Officer Drew Garty joins host Manny Vazquez as he kicks off the new season with two innovators in the industry: Doug Bain, founder and consulting partner at Clinflo, and Robert Bergann, clinical digital innovation leader at Bayer. Recorded at R&D and Quality Summit 2025 in Madrid.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Unblinded: A Clinical Trial Podcast
Deep Pockets, Short Arms: Is MedTech Ready for AI?
The Economics of Clinical Trial Outsourcing
A People-Focused Approach to a Risk-Based Future in Clinical Trials
ICH E6(R3): Shifting the Paradigm from Process to Purpose
Get summaries like this every morning.
Free AI-powered recaps of Unblinded: A Clinical Trial Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.